These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6153736)

  • 1. Inhibition of thyroid cathepsin D activity by pepstatin.
    Starling JR; Hopps BA
    J Surg Res; 1980 Jan; 28(1):8-13. PubMed ID: 6153736
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
    Kay J; Afting EG; Aoyagi T; Dunn BM
    Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain distribution of cathepsin D activity: its inhibition in vivo following central infusion of pepstatin in the rat.
    Buccafusco JJ; Goldstein BD; Greenbaum LM
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):157-60. PubMed ID: 7079582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscle.
    Iodice AA
    Life Sci; 1976 Nov; 19(9):1351-8. PubMed ID: 11385
    [No Abstract]   [Full Text] [Related]  

  • 5. Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins.
    Greenbaum LM; Sutherland JH; Narayan TK
    Adv Exp Med Biol; 1983; 156 (Pt B)():783-7. PubMed ID: 6190383
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of human cathepsin D with the inhibitor pepstatin.
    Knight CG; Barrett AJ
    Biochem J; 1976 Apr; 155(1):117-25. PubMed ID: 938470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of Triiodothyronine-induced tadpole tail-fin regression by cathepsin D-inhibitor pepstatin.
    Seshimo H; Ryuzaki M; Yoshizato K
    Dev Biol; 1977 Aug; 59(1):96-100. PubMed ID: 302228
    [No Abstract]   [Full Text] [Related]  

  • 8. Dinitrophenyl-pepstatins as active-site-directed localization reagents for cathepsin D.
    Matthews IT; Decker RS; Hornebeck W; Knight CG
    Biochem J; 1983 Apr; 211(1):139-47. PubMed ID: 6347185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of basophil histamine release induced by pepstatin A.
    Marone G; Columbo M; Soppelsa L; Condorelli M
    J Immunol; 1984 Sep; 133(3):1542-6. PubMed ID: 6205086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of aspartic proteinase inhibitors related to pepstatin.
    Gunn JM; Owens RA; Liu WS; Glover GI
    Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cathepsin D by synthetic oligopeptides.
    Lin TY; Williams HR
    J Biol Chem; 1979 Dec; 254(23):11875-83. PubMed ID: 500680
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of dinitrophenyl-pepstatins with human cathepsin D and with anti-dinitrophenyl antibody. Development of potential reagents for the localization in vivo of active proteinases at sites of tissue injury.
    Knight CG; Hornebeck W; Matthews IT; Hembry RM; Dingle JT
    Biochem J; 1980 Dec; 191(3):835-43. PubMed ID: 6793037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to prevent degeneration of insect muscles with pepstatin.
    Lockshin RA
    Life Sci; 1975 Aug; 17(3):403-10. PubMed ID: 1160510
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
    Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
    Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of thyrotropin, phorbol esters, norepinephrine, and carbachol on iodide organification in dog thyroid slices, follicles, and cultured cells.
    Rani CS; Field JB
    Endocrinology; 1988 May; 122(5):1915-22. PubMed ID: 2452073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin, carbachol, and protein kinase-C stimulators on glucose transport and glucose oxidation by primary cultures of dog thyroid cells.
    Haraguchi K; Rani CS; Field JB
    Endocrinology; 1988 Sep; 123(3):1288-95. PubMed ID: 2456912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pepstatin, an inhibitor of acid kininogenases and ascites retardant in neoplastic disease.
    Greenbaum LM
    Fed Proc; 1979 Dec; 38(13):2788-91. PubMed ID: 92421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of growth in cultured rat thyroid cells.
    Dere WH; Rapoport B
    Mol Cell Endocrinol; 1986 Mar; 44(3):195-9. PubMed ID: 2420657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroxine secretion by isolated hog thyroid cells: a cyclic AMP independent pathway.
    Rousset B; Munari Y; Rostagnat A; Mornex R
    Mol Cell Endocrinol; 1977 Nov; 9(1):33-43. PubMed ID: 201515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system.
    Mori M; Tajima K; Oda Y; Matsui I; Mashita K; Tarui S
    Endocrinology; 1989 Mar; 124(3):1365-9. PubMed ID: 2465138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.